Effector Therapeutics Inc (EFTR) — Net Asset Quality Index
Effector Therapeutics Inc (EFTR) has a Net Asset Quality Index of 3.0% as of March 2024. This metric measures the proportion of total assets financed by shareholders' equity — total assets of $27.13 Million minus total liabilities of $26.30 Million yields net assets of $827.00K. A higher index indicates a stronger, lower-leverage balance sheet. Read EFTR total debt and obligations for a breakdown of total debt and financial obligations.
Quality Index
Net Assets
Total Assets
Total Liabilities
Effector Therapeutics Inc Net Asset Quality Index Over Time (2019–2023)
This chart shows how Effector Therapeutics Inc's Net Asset Quality Index has evolved across 5 annual periods from 2019 to 2023. As of March 2024, the index stands at 3.0%, representing net assets of $827.00K against total assets of $27.13 Million USD. For live market cap and overall valuation, see Effector Therapeutics Inc (EFTR) market capitalisation.
Annual Net Asset Quality Index for Effector Therapeutics Inc (2019–2023)
The table below presents the year-by-year Net Asset Quality Index for Effector Therapeutics Inc from 2019 to 2023, covering 5 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. Check EFTR strategic assets to equity ratio to assess the company's strategic physical and investment asset allocation.
| Year | Quality Index | Net Assets (USD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2023 | -28.2% | $-5.79 Million | $20.54 Million | $26.34 Million | ▼ -41.6 pp |
| 2022 | 13.4% | $3.90 Million | $29.08 Million | $25.18 Million | ▼ -18.6 pp |
| 2021 | 32.0% | $17.28 Million | $54.06 Million | $36.77 Million | ▲ +823.7 pp |
| 2020 | -791.7% | $-132.25 Million | $16.70 Million | $148.95 Million | ▼ -520.1 pp |
| 2019 | -271.6% | $-13.84 Million | $5.09 Million | $18.93 Million | — |